Variant report
Variant | esv3394931 |
---|---|
Chromosome Location | chr3:49189548-49193146 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:10)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:10 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:49189291..49191828-chr3:49198184..49200998,3 | MCF-7 | breast: | |
2 | chr3:49187904..49189421-chr3:49189725..49191505,2 | MCF-7 | breast: | |
3 | chr3:49057515..49059041-chr3:49190402..49192580,2 | MCF-7 | breast: | |
4 | chr3:49192110..49194166-chr3:49199747..49201408,2 | MCF-7 | breast: | |
5 | chr3:49189882..49192619-chr3:49194424..49197107,3 | MCF-7 | breast: | |
6 | chr3:49191307..49193110-chr3:49202921..49204908,2 | MCF-7 | breast: | |
7 | chr3:49130528..49132725-chr3:49190413..49192087,2 | K562 | blood: | |
8 | chr3:49188624..49190754-chr3:49194222..49196176,2 | K562 | blood: | |
9 | chr3:49189296..49192749-chr3:49200382..49204173,5 | K562 | blood: | |
10 | chr3:49189254..49193305-chr3:49194676..49199783,5 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CCDC71-1 | chr3:49190292-49191834 | NONHSAT089678 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000207605 | chromatin interactions |
ENSG00000198218 | chromatin interactions |
ENSG00000178057 | chromatin interactions |
ENSG00000178149 | chromatin interactions |
ENSG00000270441 | chromatin interactions |
ENSG00000177352 | chromatin interactions |
ENSG00000199032 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187881040 | chr3:49189550-49189551 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs551043386 | chr3:49189551-49189552 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs191586186 | chr3:49189562-49189563 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs35983267 | chr3:49189611-49189612 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs28615670 | chr3:49189612-49189613 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs567458052 | chr3:49189625-49189626 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs565687015 | chr3:49189655-49189656 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs75443297 | chr3:49189711-49189712 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs538110672 | chr3:49189722-49189723 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs372494714 | chr3:49189786-49189787 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs569260371 | chr3:49189797-49189798 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs573717423 | chr3:49189836-49189837 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs539096365 | chr3:49189869-49189870 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs192853926 | chr3:49189892-49189893 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs184648291 | chr3:49189934-49189935 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs544822734 | chr3:49189935-49189936 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs573428181 | chr3:49189938-49189939 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs563386333 | chr3:49189939-49189940 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs148053850 | chr3:49189982-49189983 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs555884686 | chr3:49190011-49190012 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs536260227 | chr3:49190027-49190028 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs574014038 | chr3:49190061-49190062 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs369958225 | chr3:49190063-49190064 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs562176543 | chr3:49190150-49190151 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs373453368 | chr3:49190170-49190171 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs576714349 | chr3:49190180-49190181 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs543601987 | chr3:49190189-49190190 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs527338144 | chr3:49190239-49190240 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs548906655 | chr3:49190267-49190268 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs567421823 | chr3:49190309-49190310 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs531671667 | chr3:49190320-49190321 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs550077802 | chr3:49190330-49190331 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs186766227 | chr3:49190371-49190372 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs539834915 | chr3:49190389-49190390 | Weak transcription | Chromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs141737901 | chr3:49190409-49190410 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 6 gene(s) | Overlapped CNVs | n/a |
36 | rs371104939 | chr3:49190448-49190449 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
37 | rs566857139 | chr3:49190449-49190450 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
38 | rs555551737 | chr3:49190469-49190470 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
39 | rs150552153 | chr3:49190548-49190549 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
40 | rs555696475 | chr3:49190561-49190562 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
41 | rs36089774 | chr3:49190651-49190652 | ZNF genes & repeats Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
42 | rs117239217 | chr3:49190654-49190655 | ZNF genes & repeats Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
43 | rs191253874 | chr3:49190732-49190733 | ZNF genes & repeats Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
44 | rs559623214 | chr3:49190758-49190759 | ZNF genes & repeats Weak transcription Enhancers | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
45 | rs139328619 | chr3:49190830-49190831 | Enhancers Weak transcription Active TSS | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
46 | rs556433856 | chr3:49190926-49190927 | Enhancers Weak transcription Active TSS | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
47 | rs577258293 | chr3:49191054-49191055 | Weak transcription Active TSS | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
48 | rs544686582 | chr3:49191071-49191072 | Weak transcription Active TSS | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
49 | rs80337825 | chr3:49191075-49191076 | Weak transcription Active TSS | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
50 | rs572063040 | chr3:49191101-49191102 | Weak transcription Active TSS | Chromatin interactive regionlncRNA | 7 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Melanoma | 17363583 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
abnormal development | 18461090 | CNVD |
Developmental delay | 21147756 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:49172200-49200400 | Weak transcription | Colon Smooth Muscle | Colon |
2 | chr3:49186000-49190800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr3:49186000-49191200 | Weak transcription | Gastric | stomach |
4 | chr3:49186200-49198800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
5 | chr3:49186800-49198800 | Weak transcription | Pancreas | Pancrea |
6 | chr3:49187800-49191200 | Weak transcription | Esophagus | oesophagus |
7 | chr3:49189400-49189600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr3:49189600-49190600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr3:49190000-49195400 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
10 | chr3:49190400-49190600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
11 | chr3:49190600-49190800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr3:49190600-49191000 | Enhancers | Ovary | ovary |
13 | chr3:49190800-49191000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr3:49190800-49191400 | Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
15 | chr3:49191000-49198800 | Weak transcription | Ovary | ovary |
16 | chr3:49191000-49199800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr3:49191200-49191400 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
18 | chr3:49191200-49191400 | Enhancers | Gastric | stomach |
19 | chr3:49191200-49191600 | Enhancers | Esophagus | oesophagus |
20 | chr3:49191400-49192000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
21 | chr3:49191400-49198800 | Weak transcription | Gastric | stomach |
22 | chr3:49191400-49199000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
23 | chr3:49191600-49200200 | Weak transcription | Esophagus | oesophagus |
24 | chr3:49192000-49192200 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
25 | chr3:49192000-49198000 | Weak transcription | Thymus | Thymus |
26 | chr3:49192200-49198600 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |